bpc-157 human clinical trials dosing protocol BPC-157 Dosing (Common Protocols) πΉ Oral / Subcutaneous β’ 500 mcg daily β’ Duration: 6 weeks πΉ Intramuscular / Peritendinous β’ 1 mg daily β’ Duration: 6 weeks β οΈ Note: Not approved How Much BAC Water for
Description
Above 25 C or for 24+ hours, assume degradation and discard
The administration of 48 IU IN-OXT to SZ patients and age-matched controls followed by facial emotion matching and control tasks failed to show any improvement in facial affect processing, contradicting previous results with IN-OXT [166]
The most common diluent that researchers and clinics will use is bacteriostatic water
Its more common when a cannula is used
